OOIR: Observatory of International Research

Papers

(The H4-Index of Neurobiology of Disease is 44. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-07-01 to 2025-07-01.)

Article	Citations
Aberrant splicing of mutant huntingtin in Huntington's disease knock-in pigs	168
Estrogen-related receptor gamma is a regulator of mitochondrial, autophagy, and immediate-early gene programs in spiny projection neurons: Relevance for transcriptional changes in Huntington disease	161
New perspectives on the role of biological factors in anorexia nervosa: Brain volume reduction or oxidative stress, which came first?	117
The predictive value of mBDNF for major adverse cardiovascular events in stable coronary artery disease patients with depressive symptoms: A single-center, 5-year follow-up study	103
Impaired plasticity of intrinsic excitability in the dentate gyrus alters spike transfer in a mouse model of Alzheimer's disease	99
Identification of an epilepsy-linked gut microbiota signature in a pediatric rat model of acquired epilepsy	93
Key role of the gut–microbiota–brain axis via the subdiaphragmatic vagus nerve in demyelination of the cuprizone-treated mouse brain	87
The neoliberal leaning of the neuroscience discourse when it deals with mental health and learning disorders	86
The altered sensitivity of acute stress induced anxiety-related behaviors by modulating insular cortex-paraventricular thalamus-bed nucleus of the stria terminalis neural circuit	85
Cellular iron deposition patterns predict clinical subtypes of multiple system atrophy	84
Postnatal Foxp2 regulates early psychiatric-like phenotypes and associated molecular alterations in the R6/1 transgenic mouse model of Huntington's disease	74
Evoked resonant neural activity in subthalamic local field potentials reflects basal ganglia network dynamics	74
Nicotinamide riboside modulates the reactive species interactome, bioenergetic status and proteomic landscape in a brain-region-specific manner	70
Brain organoid models for studying the function of iPSC-derived microglia in neurodegeneration and brain tumours	70
Stem cell therapy for central nervous system disorders: Metabolic interactions between transplanted cells and local microenvironments	68
Plasma lysosphingolipids in GRN-related diseases: Monitoring lysosomal dysfunction to track disease progression	65
Gut-brain axis in the pathogenesis of sepsis-associated encephalopathy	63
Interhemispheric reactivity of the subthalamic nucleus sustains progressive dopamine neuron loss in asymmetrical parkinsonism	62
MicroRNA signature of lymphoblasts from amyotrophic lateral sclerosis patients as potential clinical biomarkers	60
Intermittent fasting produces antidepressant-like effects by modulating dopamine D1 receptors in the medial prefrontal cortex	59
Serotonin innervation of the subthalamic nucleus in parkinsonian monkeys	58
CCR5 deficiency normalizes TIMP levels, working memory, and gamma oscillation power in APOE4 targeted replacement mice	57
Genetic diversity of axon degenerative mechanisms in models of Parkinson's disease	56
Caffeine consumption outcomes on amyotrophic lateral sclerosis disease progression and cognition	55
Amyloid beta peptides (Aβ) from Alzheimer's disease neuronal secretome induce endothelial activation in a human cerebral microvessel model	55

A novel role for the ADHD risk gene latrophilin-3 in learning and memory in Lphn3 knockout rats	55
Perturbation of serine enantiomers homeostasis in the striatum of MPTP-lesioned monkeys and mice reflects the extent of dopaminergic midbrain degeneration	54
Inflammation in dementia with Lewy bodies	54
Diagnostic and prognostic value of the RUNXOR/RUNX1 axis in multiple sclerosis	53
The association of epigenetic clocks in brain tissue with brain pathologies and common aging phenotypes	53
T cell infiltration mediates neurodegeneration and cognitive decline in Alzheimer's disease	53
miR-23a suppression accelerates functional decline in the rNLS8 mouse model of TDP-43 proteinopathy	52
Sunitinib-mediated inhibition of STAT3 in skeletal muscle and spinal cord does not affect the disease in a mouse model of ALS	51
Early suppression of excitability in subcortical band heterotopia modifies epileptogenesis in rats	51
Epigenomic analysis of Alzheimer's disease brains reveals diminished CTCF binding on genes involved in synaptic organization	50
Epm2aR240X knock-in mice present earlier cognitive decline and more epileptic activity than Epm2a mice	50
Potential clinical and biochemical markers for the prediction of drug-resistant epilepsy: A literature review	50
Sphingosine 1-phosphate receptor subtype 1 (S1P1) activity in the course of Alzheimer's disease	49
Protective Alzheimer's disease-associated APP A673T variant predominantly decreases sAPPβ levels in cerebrospinal fluid and 2D/3D cell culture models	49
Neonatal stroke enhances interaction of microglia-derived extracellular vesicles with microglial cells	48
14-3-3θ phosphorylation exacerbates alpha-synuclein aggregation and toxicity	47
Alternative platelet activation pathways and their role in neurodegenerative diseases	45
Corrigendum to “Upregulation of tripeptidyl-peptidase 1 by 3-hydroxy-(2,2)-dimethyl butyrate, a brain endogenous ligand of PPARα: Implications for late-infantile Batten disease therapy” [Neurobiology	44
B cell depletion modulates glial responses and enhances blood vessel integrity in a model of multiple sclerosis	44